These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors. Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217 [TBL] [Abstract][Full Text] [Related]
3. In silico analyses of acetylcholinesterase (AChE) and its genetic variants in interaction with the anti-Alzheimer drug Rivastigmine. Pereira GRC; Gonçalves LM; Abrahim-Vieira BA; De Mesquita JF J Cell Biochem; 2022 Jul; 123(7):1259-1277. PubMed ID: 35644025 [TBL] [Abstract][Full Text] [Related]
4. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment. Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176 [TBL] [Abstract][Full Text] [Related]
5. Constituents of Stachys plants as potential dual inhibitors of AChE and NMDAR for the treatment of Alzheimer's disease: a molecular docking and dynamic simulation study. Touati I; Abdalla M; Ali NH; AlRuwaili R; Alruwaili M; Britel MR; Maurady A J Biomol Struct Dyn; 2024 Mar; 42(5):2586-2602. PubMed ID: 37325873 [TBL] [Abstract][Full Text] [Related]
6. Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study. Rocha REO; Lima LHF J Biomol Struct Dyn; 2019 Apr; 37(7):1843-1856. PubMed ID: 29697300 [TBL] [Abstract][Full Text] [Related]
7. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study. Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419 [TBL] [Abstract][Full Text] [Related]
8. A Novel spice-antioxidant-based nano-vehicle as a putative green alternative of synthetic AChE inhibitor drugs. Kamal IM; Das A; Datta S; Paul K; Chakrabarti S; Chakrabarti S; Bhattacharjee P J Biomol Struct Dyn; 2024 Oct; 42(17):8813-8830. PubMed ID: 37639732 [TBL] [Abstract][Full Text] [Related]
9. A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations. Azmal M; Hossen MS; Shohan MNH; Taqui R; Malik A; Ghosh A PLoS One; 2024; 19(6):e0304490. PubMed ID: 38833492 [TBL] [Abstract][Full Text] [Related]
10. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations. Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156 [TBL] [Abstract][Full Text] [Related]
11. Molecular docking and molecular dynamics approach to identify potential compounds in Tung BT; Hang TTT; Kim NB; Nhung NH; Linh VK; Thu DK J Complement Integr Med; 2022 Dec; 19(4):955-965. PubMed ID: 35621378 [TBL] [Abstract][Full Text] [Related]
12. 2D-QSAR, molecular docking and MD simulation based virtual screening of the herbal molecules against Alzheimer's disorder: an approach to predict CNS activity. Thakur A; Sharma B; Parashar A; Sharma V; Kumar A; Mehta V J Biomol Struct Dyn; 2024; 42(1):148-162. PubMed ID: 36970779 [TBL] [Abstract][Full Text] [Related]
13. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease. Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408 [TBL] [Abstract][Full Text] [Related]
14. Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies. Ali MR; Sadoqi M; Møller SG; Boutajangout A; Mezei M J Mol Graph Model; 2017 Sep; 76():36-42. PubMed ID: 28711758 [TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibitory activities of some flavonoids from the root bark of Cuong NM; Khanh PN; Nhung LTH; Ha NX; Huong TT; Bauerova K; Kim YH; Tung DD; Thuy TT; Anh NTH J Biomol Struct Dyn; 2024 Jun; 42(9):4888-4901. PubMed ID: 37325850 [TBL] [Abstract][Full Text] [Related]
16. Molecular engineering and activity improvement of acetylcholinesterase inhibitors: Insights from 3D-QSAR, docking, and molecular dynamics simulation studies. Gao W; Ma X; Yang H; Luan Y; Ai H J Mol Graph Model; 2022 Nov; 116():108239. PubMed ID: 35696774 [TBL] [Abstract][Full Text] [Related]
17. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. Gurung AB; Aguan K; Mitra S; Bhattacharjee A J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776 [TBL] [Abstract][Full Text] [Related]
18. Biocomputational Screening of Natural Compounds against Acetylcholinesterase. Ahmad SS; Khan MB; Ahmad K; Lim JH; Shaikh S; Lee EJ; Choi I Molecules; 2021 Apr; 26(9):. PubMed ID: 33946559 [TBL] [Abstract][Full Text] [Related]
19. Screening and identification of secondary metabolites in the bark of Khare N; Maheshwari SK; Jha AK J Biomol Struct Dyn; 2021 Oct; 39(16):5988-5998. PubMed ID: 32720564 [TBL] [Abstract][Full Text] [Related]
20. Computational Prediction of 3,5-Diaryl-1H-Pyrazole and spiropyrazolines derivatives as potential acetylcholinesterase inhibitors for alzheimer disease treatment by 3D-QSAR, molecular docking, molecular dynamics simulation, and ADME-Tox. El Alaouy MA; Alaqarbeh M; Ouabane M; Zaki H; ElBouhi M; Badaoui H; Moukhliss Y; Sbai A; Maghat H; Lakhlifi T; Bouachrine M J Biomol Struct Dyn; 2024 Nov; 42(18):9547-9560. PubMed ID: 37655700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]